Two terms used interchangeably far too often
Quick answer
Stem cells are living cells that respond to the body's environment; exosomes are nanoscale vesicles released by cells, carrying proteins and RNA but not alive. Both are studied for reducing inflammation and supporting kidney regeneration, yet neither is proven superior in CKD and neither is standard care.
Exosomes are theoretically easier to store, carry no risk of aberrant cell division and allow clearer dosing. Their limitation is the absence of the adaptive behaviour living cells show.
A market problem: the word exosome covers everything from topical products to intravenous preparations, with no shared standard for quantification or purity, so prices cannot be compared like for like.
Ask any provider about the source cells, purification method, particle quantification, sterility testing and batch documentation. Incomplete answers should be read as risk.
Some risks are lower, but safety depends mainly on manufacturing quality.
Not always, but unusually low prices often come with unverifiable production data.
Some providers offer that, but supporting evidence is thin; beware added cost without data.
Oral products claiming renal effects lack evidence and warrant strong scepticism.
Pick the programme with real renal-marker follow-up and complete quality documentation rather than by product type.
5 points • reviewed 2026-09-02
Reviewed and last updated: 2026-09-02
5 sources • every claim is traceable
https://www.ehlbio.co.kr
https://www.mfds.go.kr/eng/index.do
https://www.mohw.go.kr/eng/
https://pubmed.ncbi.nlm.nih.gov/
https://www.medicalkorea.or.kr/
Last updated: 2026-09-02 · This content is for information only and is not medical advice. Consult a qualified doctor before making treatment decisions.
Back to categories